- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 17.09M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 18.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 56.33M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $13.46K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $407.58K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $233.83K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.79M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.77M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $210.76K |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $440.04K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $6.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.37M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.77M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7.12M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.48M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.71M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $18.55M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $18.89M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.14K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $66.85K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$401.51K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$94.37K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$325.86K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$90.94K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $185.33K |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $1.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.89M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.08M |